MF
TARS icon

Magnetar Financial’s Tarsus Pharmaceuticals TARS Stock Holding History

Magnetar Financial’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
+7,121
New +$455K ﹤0.01% 644
2025
Q3 		– Sell
-14,721
Closed -$596K – 1178
2025
Q2 		$596K Buy
+14,721
New +$662K ﹤0.01% 524

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Magnetar Financial's TARS Position: Q2 2026 in Review

Magnetar Financial opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 7,121 shares worth $448K. The stake represents ﹤0.01% of the portfolio and ranks #644 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in TARS as recently as Q2 2025.

Magnetar Financial first reported a position in TARS in Q2 2025 and has held it in 2 quarters since. The position peaked at $596K in Q2 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Magnetar Financial held 7,121 shares of Tarsus Pharmaceuticals worth $448K as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Magnetar Financial position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #644 holding.
  • Magnetar Financial first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Magnetar Financial's Tarsus Pharmaceuticals position peaked at $596K in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.